InvestorsHub Logo
Followers 312
Posts 24877
Boards Moderated 9
Alias Born 10/26/2008

Re: None

Saturday, 04/10/2021 6:26:20 AM

Saturday, April 10, 2021 6:26:20 AM

Post# of 176
April 7, 2021...
The combination of pepinemab with avelumab was well tolerated in NSCLC and showed signs of antitumor activity in immunotherapy resistant and PD-L1 negative / low tumors.

https://clincancerres.aacrjournals.org/content/early/2021/04/06/1078-0432.CCR-20-4792


Insiders buying bigly

look-em-up
VCNX News: Statement of Changes in Beneficial Ownership (4) 04/02/2021 04:28:58 PM
VCNX News: Statement of Changes in Beneficial Ownership (4) 04/02/2021 04:28:01 PM
VCNX News: Statement of Changes in Beneficial Ownership (4) 04/02/2021 04:26:21 PM
VCNX News: Statement of Changes in Beneficial Ownership (4)



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VCNX News